545
Participants
Start Date
September 19, 2013
Primary Completion Date
March 16, 2018
Study Completion Date
August 31, 2018
Nintedanib
triple kinase inhibitor; 200mg starting dose
Pemetrexed
backbone chemo
Cisplatin
backbone chemo
Cisplatin
backbone chemo
Pemetrexed
backbone chemo
Placebo
Nintedanib matching placebo
AKH - Medical University of Vienna, Vienna
Brussels - UNIV Saint-Luc, Brussels
Northern Cancer Institute, St Leonards
Rigshospitalet, København, Onkologisk afdeling, Købenahvn Ø
Calvary Mater Newcastle Hospital, Waratah
Edegem - UNIV UZ Antwerpen, Edegem
AZ Sint-Maarten, Mechelen
UZ Leuven, Leuven
Austin Health, Heidelberg
Box Hill Hospital, Box Hill
Peninsula Haematology & Oncology, Frankston
Border Onclogy Research, Wodonga
The Prince Charles Hospital, Chermside
Mater Cancer Care Centre, South Brisbane
Klinikum Wels - Grieskirchen GmbH, Wels
Perth Oncology, Perth
Sir Charles Gairdner Hospital, Nedlands
LKH Leoben, Leoben
UNIV UZ Gent, Ghent
University Clinic for Pulmonary Diseases, Zagreb
Azienda Sanitaria Ospedale S. Luigi Gonzaga, Orbassano (TO)
National Cancer Institute, Cairo University, Cairo
Vivantes Netzwerk für Gesundheit GmbH, Berlin
Nasser Institute, Cairo
HOP Nord, Marseille
HOP Côte de Nacre, Caen
Instituto Nacional de Cancerologia, México
Helios Klinikum Emil von Behring, Berlin
Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria
University of Pittsburgh Medical Center, Pittsburgh
Istituto Nazionale per la Ricerca sul Cancro, Genova
Hospital Universitario Donostia, Donostia (Gipuzkoa)
Clinical Research Center Alexandria, Alexandria
Medical Research Institute, Alexandria
Pneumologisches Forschungsinstitut an der LungenClinic Grosshansdorf GmbH, Großhansdorf
Humanitas Gavazzeni, Bergamo
Eskisehir Osmangazi Üni. Sag. Uygulama ve Arastirma Has., Eskişehir
Hospital Ramón y Cajal, Madrid
Hospital Virgen de la Victoria, Málaga
HOP Morvan, Brest
Greenville Health System, Greenville
HOP Larrey, Toulouse
Rambam Medical Center, Haifa
Centro Oncologico de Chihuahua, Chihuahua City
CLI Bordeaux Nord Aquitaine, Bordeaux
Centro di riferimento Oncologico, Aviano (PN)
Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi, Istanbul
Dr.Suat Seren EAH, Izmir
University of Alabama at Birmingham, Birmingham
Hospital Virgen del Rocío, Seville
Hospital Clínico de Valencia, Valencia
Hospital Universitario de Cruces, Barakaldo (Vizcaya)
Rabin Medical Center Beilinson, Petah Tikva
Centro Oncologico Estatal ISSEMYM, Toluca
A.O.U. Senese Policlinico Santa Maria alle Scotte, Siena
HOP Calmette, Lille
Sourasky Medical Center, Tel Aviv
Universitätsklinikum des Saarlandes, Homburg/Saar
Thoraxklinik-Heidelberg gGmbH am Universitätsklinikum Heidelberg, Heidelberg
HOP Lyon Sud, Pierre-Bénite
Klinik Schillerhöhe GmbH, Gerlingen
Klinik, Löwenstein, Löwenstein
The University of Texas MD Anderson Cancer Center, Houston
Texas Oncology-San Antonio Northeast, San Antonio
Texas Oncology - McAllen, McAllen
HOP HIA Saint-Anne, Toulon
Comprehensive Cancer Centers of Nevada, Henderson
University of California San Francisco, San Francisco
INS Gustave Roussy, Villejuif
Cancer Care Northwest Centers, PS, Spokane Valley
"FSBI N.N Blokhin Med.Res.Cent.Onc.MoH of RF", Moscow
1stPavlov St.Med.Univ.St.-Petersburg Res.Inst., Saint Petersburg
"FSBI N.N. Petrov National Medical Research Center of Oncology of MoH of RF", Saint Petersburg
"St.Auton.Heal.Inst.Rep.Clin.Onc.Disp.of MoH of Rep. Tatarstan", Kazan'
SBI HC-Rep.Clin.Onc.Disp.MoH.Rep.Bashkortostan, Ufa
"St.Budg.Heal.Inst.Chelyabinsk Reg.Clin.Cen.Onc&Nucl.Med", Chelyabinsk
Orlandi Oncologia, Vitacura
Centro Internacional de Estudios Clínicos - CIEC, Recoleta
Rocky Mountain Cancer Centers, Littleton
Sanatorio Güemes, Ciudad Autónoma de Bs As
Instituto Medico Especializado Alexander Fleming, Ciudad Autónoma de Bs As
Clínica Universitaria Reina Fabiola, Córdoba
QEII Health Sciences Centre (Dalhousie University), Halifax
Health Sciences North, Greater Sudbury
Princess Margaret Cancer Centre, Toronto
IUCPQ (Laval University), Québec
University Hospital Brno, Brno
University Hospital Olomouc, Olomouc
University Hospital of Occupational and Environmental Health, Fukuoka, Kitakyushu
Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Amagasaki
Hyogo College of Medicine Hospital, Hyogo, Nishinomiya
Yokosuka Kyosai Hospital, Kanagawa , Yokosuka
Japan Labour Health and Safety Organization Okayama Rosai Hospital, Okayama, Okayama
Kindai University Hospital, Osaka, OsakaSayama
Otemae Hospital, Osaka, Osaka
Juntendo University Hospital, Tokyo, Bunkyo-ku
Medisch Spectrum Twente, Enschede
Zuyderland Medisch Centrum, Heerlen
Erasmus Medisch Centrum, Rotterdam
Oslo Universitetssykehus HF, Radiumhospitalet, Oslo
St. Olavs Hospital, Universitetssykehuset i Trondheim, Trondheim
University Clinical Center, Gdansk, Gdansk
Clin.Hosp.Med.Univ.Marcinkowski in Poznan, Poznan
Greater PL Cent.Pulmo.&Thor.Surg.Eugenia&Janusz Zeyland, Poznan
Onco.Cent. - Instit. of Maria Sklodowskiej-Curie, Warsaw
Centro Hospitalar Lisboa Norte Hospital Pulido Valente, Lisbon
Hospital CUF Porto, Porto
Wilgers Oncology Centre, Pretoria
Hospital Vall d'Hebron, Barcelona
Hospital Clínic de Barcelona, Barcelona
Hospital Duran i Reynals, L'Hospitalet de Llobregat
Sahlgrenska US, Göteborg, Gothenburg
Universitetssjukhuset, Linköping, Linköping
Skånes universitetssjukhus, Lund, Lund
Karolinska Univ. sjukhuset, Stockholm
Akademiska sjukhuset, Uppsala
Western General Hospital, Edinburgh
Beatson West of Scotland Cancer Centre, Glasgow
Leicester Royal Infirmary, Leicester
Guy's Hospital, London
The Royal Marsden Hospital, London
The Royal Marsden Hospital, Sutton
Wythenshawe Hospital, Wythenshawe
Lead Sponsor
Boehringer Ingelheim
INDUSTRY